Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03DC03	LUKAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	783,460 L.L
R03DC03	LUKAST	G	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	783,460 L.L
R03DC03	LEUKOTRIS	G	Montelukast - 10mg	10mg	Tablet	981,645 L.L
R03DC03	LEUKOTRIS	G	Montelukast - 4mg	4mg	Tablet	783,268 L.L
R03DC03	LEUKOTRIS	G	Montelukast - 5mg	5mg	Tablet	979,085 L.L
J01MA14	LOXIMED	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet	851,100 L.L
J01MA14	LOXIPHAR	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet	1,063,555 L.L
C08CA08	LUSOPRESS	B	Nitrendipine - 20mg	20mg	Tablet, scored	757,927 L.L
L01XK01	LYNPARZA	B	Olaparib - 100mg	100mg	Tablet, film coated	230,789,350 L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	230,789,350 L.L
A02BC01	LOZICARE	G	Omeprazole - 40mg	40mg	Injectable powder for solution	12,446,972 L.L
A08AB01	LESSFAT	G	Orlistat - 120mg	120mg	Capsule	391,634 L.L
A08AB01	LESSFAT	G	Orlistat - 60mg	60mg	Capsule	1,039,238 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	4,146,714 L.L
A08AA01	LOMAIRA	B	Phentermine Hydrochloride - 8mg	8mg	Tablet	6,138,673 L.L
C10AA08	LIVAZO	B	Pitavastatin - 2mg	2mg	Tablet, film coated	1,558,857 L.L
C10AA08	LIVAZO	B	Pitavastatin - 4mg	4mg	Tablet, film coated	1,835,305 L.L
B05BB02	LO-SODIUM WITH POTASSIUM INJECTION	G	Potassium chloride - 0.149g/100ml, Sodium dihydrogenophosphate - 0.137g/100ml, Sodium lactate - 0.223g/100ml, Sodium chloride - 0.0585g/100ml, Dextrose monohydrate - 5g/100ml		Injectable solution	165,727 L.L
S01CA02	LOXTRA	G	Prednisolone acetate - 2mg/ml, Tetrahydrozoline HCl - 0.4mg/ml, Ofloxacin - 3mg/ml		Drops suspension	423,310 L.L
N02BF02	LYRICA	B	Pregabalin - 150mg	150mg	Capsule	3,041,116 L.L
N02BF02	LYRICA	B	Pregabalin - 150mg	150mg	Capsule	3,041,116 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	598,010 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	2,131,334 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	598,010 L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	L.L
S01LA04	LUCENTIS	BioTech	Ranibizumab - 10mg/ml	10mg/ml	Injectable solution	51,255,093 L.L
C10AA07	LIPIROSE OBP 10	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	575,933 L.L
C10BA06	LIPOCOMB	B	Rosuvastatin (calcium) - 10mg, Ezetimibe - 10mg		Capsule, hard	2,701,123 L.L

...